Resources

Latest data on the safety and effectiveness of COVID-19 vaccines in children

Information covering CDC recommendation of pediatric COVID-19 vaccine for children ages 5-11, and original emergency use authorization from May 2021 for children 12-15.

Our evolution is a job that is never done

The work of scientific discovery is never done but is continuously improving, and such is also the case for CAS.

CAS launches new brand reflecting strategic evolution to empower smarter science

CAS launched a new brand reflecting the broadening scope of its solutions and capabilities critical to advancing scientific discovery. This new brand mirrors an on-going evolution to enable new and smarter uses of scientific information as a partner to R&D leaders pursuing more efficient, collaborative, and customized innovation models.

Novel oligonucleotide with application in mRNA vaccine quality control gets 250 millionth CAS Registry Number

Novel oligonucleotide from Moderna, with application in mRNA vaccine quality control, marks the 250 millionth substance registration in CAS REGISTRY.

The Latest COVID-19 Vaccine Questions Answered

Answers to frequently asked questions regarding the safety, efficacy, and composition of the currently available Covid vaccines. Updated March 26, 2021.

CAS Common Chemistry™ expands collection of publicly available chemical information

CAS has expanded the open access Common Chemistry resource to nearly 500,000 substances from CAS REGISTRY®. The collection represents substances commonly found in consumer products, regulatory lists, and introductory chemistry curricula.

New AI-Enabled Virtual Screening Tool Identifies Most Promising Approved Drugs for Success in Treating COVID-19

WorldQuant Predictive (WQP) and CAS have partnered to develop a groundbreaking methodology that can save time and lives by helping researchers rapidly prioritize the most promising drug candidates to treat COVID-19 and other critical diseases.

Do other vaccines protect you from COVID-19?

Research has revealed correlations between COVID-19 severity and a patient’s vaccination history.

Drugs approved by the FDA in 2020 reflect continuing trend of structural innovation